This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Verva Pharmaceuticals Ltd, Naia Metabolic, Inc.. Active years: 2013-2019.
Company Filing History:
Years Active: 2013-2019
Title: Nicky Konstantopoulos: Innovator in Insulin Sensitizers
Introduction
Nicky Konstantopoulos is a notable inventor based in Richmond, Australia. She has made significant contributions to the field of therapy, particularly in the development of insulin sensitizers. With a total of 3 patents to her name, her work focuses on improving glucose homeostasis and addressing conditions related to insulin resistance.
Latest Patents
One of her latest patents involves insulin sensitizers and methods of treatment. This invention relates to therapeutic approaches for regulating glucose homeostasis and treating diseases such as diabetes, syndrome X, hyperglycaemia, vascular disease, and kidney disease. The patent outlines various compounds, agents, and compositions that can be utilized in these treatment methods.
Career Highlights
Throughout her career, Nicky has worked with several companies, including Verva Pharmaceuticals Ltd and Naia Metabolic, Inc. Her experience in these organizations has allowed her to develop her innovative ideas and contribute to advancements in medical therapies.
Collaborations
Nicky has collaborated with professionals such as Juan-Carlos Molero-Navajas and Kenneth Russell Walder. These partnerships have further enriched her research and development efforts in the field of insulin sensitizers.
Conclusion
Nicky Konstantopoulos is a pioneering inventor whose work in insulin sensitizers has the potential to impact the treatment of various diseases related to insulin resistance. Her contributions to the field of therapy are noteworthy and continue to inspire advancements in medical science.